Camille L. Bedrosian - EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP and Chief Medical Officer
Stock Symbol
RARE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Camille L. Bedrosian since 10/5/2023

Holdings reported by Camille L. Bedrosian for Ultragenyx Pharmaceutical Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 46.7K $981K $21.00 Mar 1, 2023 Direct

Transactions reported by Camille L. Bedrosian for Ultragenyx Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.